{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:21:46Z","timestamp":1778998906620,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejpb.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T12:15:05Z","timestamp":1620389705000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data"],"prefix":"10.1016","volume":"165","author":[{"given":"Jibin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Spivey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svitlana","family":"Silchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gonzalez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marival","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael J.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.05.003_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-015-1773-4","article-title":"The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers","volume":"33","author":"Parr","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.05.003_b0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2016.06.011","article-title":"Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant","volume":"91","author":"Bu","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0015","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1021\/acs.molpharmaceut.0c00023","article-title":"Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats","volume":"17","author":"Ruiz-Picazo","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0020","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1208\/s12249-018-0996-1","article-title":"Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution\/Absorption Simulating System and pH Alteration","volume":"19","author":"Li","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.05.003_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105164","article-title":"In vitro dissolution absorption system (IDAS2): Use for the prediction of food viscosity effects on drug dissolution and absorption from oral solid dosage forms","volume":"143","author":"Silchenko","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0030","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/acs.molpharmaceut.6b00044","article-title":"Advantage of the Dissolution\/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage","volume":"13","author":"Miyaji","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejpb.2016.02.002","article-title":"Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process","volume":"101","author":"Kataoka","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/03639045.2019.1701004","article-title":"Near infrared (NIR)-spectroscopy and in-vitro dissolution absorption system 2 (IDAS2) can help detect changes in the quality of generic drugs","volume":"46","author":"Jim\u00e9nez-Romero","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0045","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1023\/A:1026107906191","article-title":"In Vitro System to Evaluate Oral Absorption of Poorly Water-Soluble Drugs: Simultaneous Analysis on Dissolution and Permeation of Drugs","volume":"20","author":"Kataoka","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.05.003_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105532","article-title":"Dissolution\/permeation with PermeaLoop\u2122: Experience and IVIVC exemplified by Dipyridamole enabling formulations","volume":"154","author":"Eriksen","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpb.2012.07.009","article-title":"Drug precipitation-permeation interplay: Supersaturation in an absorptive environment","volume":"82","author":"Bevernage","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.09.001","article-title":"Dynamic dissolution-\/permeation-testing of nano- and microparticle formulations of fenofibrate","volume":"96","author":"Sironi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2014.07.012","article-title":"Application of a continuous intrinsic dissolution-permeation system for relative bioavailability estimation of polymorphic drugs","volume":"473","author":"Zhou","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejpb.2014.09.009","article-title":"A new in vitro system for evaluation of passive intestinal drug absorption: Establishment of a double artificial membrane permeation assay","volume":"88","author":"Kataoka","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption - Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0080","first-page":"581","article-title":"Dissolution\/permeation: The importance of the experimental setup for the prediction of formulation effects on fenofibrate in vivo performance","volume":"72","author":"Forner","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2021.05.003_b0085","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.xphs.2019.01.032","article-title":"Simultaneous Analysis of Dissolution and Permeation Profiles of Nanosized and Microsized Formulations of Indomethacin Using the In Vitro Dissolution Absorption System 2","volume":"108","author":"Li","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejpb.2021.05.003_b0095","doi-asserted-by":"crossref","unstructured":"E.R. Morey, D.J. Baylink, Inhibition of bone formation during space flight, Science (80-.) 201 (1978) 1138\u20131141. https:\/\/doi.org\/10.1126\/science.150643.","DOI":"10.1126\/science.150643"},{"key":"10.1016\/j.ejpb.2021.05.003_b0100","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2021.05.003_b0105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12247-019-09404-5","article-title":"In Vitro and In Vivo Assessment of the Potential of Supersaturation to Enhance the Absorption of Poorly Soluble Basic Drugs","volume":"15","author":"Li","year":"2020","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2021.05.003_b0110","unstructured":"Division of Assurances, Office of Laboratory Animal Welfare (OLAW), Assurance # D16-00858 (A4653-01), (n.d.). https:\/\/olaw.nih.gov (accessed February 1, 2021)."},{"key":"10.1016\/j.ejpb.2021.05.003_b0115","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/j.xphs.2020.05.019","article-title":"Suitability of the z-Factor for Dissolution Simulation of Solid Oral Dosage Forms: Potential Pitfalls and Refinements","volume":"109","author":"Hofs\u00e4ss","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test","volume":"23","author":"Takano","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.05.003_b0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1011071401306","article-title":"Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration","volume":"18","author":"Nicolaides","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.05.003_b0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acs.molpharmaceut.5b00808","article-title":"Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption","volume":"13","author":"Jakubiak","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0135","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2021.05.003_b0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2010.07.027","article-title":"Computational oral absorption simulation of free base drugs","volume":"398","author":"Sugano","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.05.003_b0150","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/jps.24447","article-title":"In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model","volume":"104","author":"Lozoya-Agullo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bdd.548","article-title":"In situ kinetic modelling of intestinal efflux in rats: Functional characterization of segmental differences and correlatlon with in vitro results","volume":"28","author":"Gonz\u00e1lez-Alvarez","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2021.05.003_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s102380200018","article-title":"A simple new method to calculate small intestine absorptive surface in the rat","volume":"2","author":"Kisielinski","year":"2002","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejpb.2021.05.003_b0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0016-5085(73)80009-5","article-title":"Gastric and Intestinal Transit in Rats Measured by a Radioactive Test Meal","volume":"64","author":"Purdon","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2021.05.003_b0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000197947","article-title":"Transit time changes with age in the gastrointestinal tract of the rat","volume":"14","author":"Varga","year":"1976","journal-title":"Digestion"},{"key":"10.1016\/j.ejpb.2021.05.003_b0175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0090-9556(25)06833-3","article-title":"The disposition and pharmacokinetics of Ketoconazole in the rat","volume":"15","author":"Remmel","year":"1987","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2021.05.003_b0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2131\/jts.5.339","article-title":"Comparative studies on the fate of 14C-Dipyridamole (RA8) after single and multiple administration in rats","volume":"5","author":"Kobayashi","year":"1980","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2014.10.017","article-title":"Concomitant intake of alcohol may increase the absorption of poorly soluble drugs","volume":"67","author":"Fagerberg","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0190","unstructured":"J. Fagerberg, Experimental and Computational Predictions of Drug Solubility in Human Gastrointestinal Fluids, 2014. http:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:uu:diva-221249 (accessed December 18, 2020)."},{"key":"10.1016\/j.ejpb.2021.05.003_b0195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ejpb.2021.05.003_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105001","article-title":"Biphasic drug release testing coupled with diffusing wave spectroscopy for mechanistic understanding of solid dispersion performance","volume":"137","author":"Jankovic","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030272","article-title":"On the usefulness of two small-scale in vitro setups in the evaluation of luminal precipitation of lipophilic weak bases in early formulation development","volume":"12","author":"O\u2019Dwyer","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.05.003_b0210","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1208\/s12249-018-0999-y","article-title":"Impact of Physicochemical Properties of Cellulosic Polymers on Supersaturation Maintenance in Aqueous Drug Solutions","volume":"19","author":"Hong","year":"2018","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2021.05.003_b0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.xphs.2018.10.051","article-title":"Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs","volume":"108","author":"Patel","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0220","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/jps.24090","article-title":"A combination turbidity and supernatant microplate assay to rank-order the supersaturation limits of early drug candidates","volume":"103","author":"Morrison","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/bdd.1803","article-title":"Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus","volume":"33","author":"Mudie","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2021.05.003_b0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.12.010","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration","volume":"136","author":"Butler","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.05.003_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27957-2","article-title":"Acute Exposure to Commonly Ingested Emulsifiers Alters Intestinal Mucus Structure and Transport Properties","volume":"8","author":"Lock","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2021.05.003_b0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jps.20541","article-title":"Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers","volume":"95","author":"Li","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.05.003_b0245","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijpharm.2019.05.028","article-title":"Application of an automated small-scale in vitro transfer model to predict in vivo precipitation inhibition","volume":"565","author":"Jede","year":"2019","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:42:21Z","timestamp":1760546541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S0939641121001272"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}